The present invention is generally related to medical devices and methods and, in particular, to devices and methods for filling and retaining fluid drug in the ear canal of a human patient.
The present invention provides systems and methods useful for anesthetizing the tympanic membrane and/or the ear canal of a patient in preparation for a surgical procedure, including the placement of a tympanostomy tube (or pressure equalization tube) across a tympanic membrane of an ear. Additionally, the invention provides systems and methods for administering and retaining fluid in the ear canal of a human patient for treatment of the ear canal and/or the tympanic membrane.
Otitis media is among the most common diagnoses made by pediatricians. A majority of children may have at least one episode of otitis media (“ear infection”) prior to their third birthday. Otitis media is often caused by an inability of the Eustachian tube to drain fluid from the middle ear. Otitis media is often treated with antibiotics.
A significant number of children exhibit recurrent episodes of otitis media and/or otitis media with effusion. Treatment of these more severe cases often involves the placement of a tympanostomy tube across the tympanic membrane to provide adequate drainage and/or ventilation of the middle ear and reduce the likelihood of future infections. Tympanostomy tubes provide fluid communication between the middle and outer ear (e.g., pressure equalization) and typically fall out spontaneously within about a year of placement. Tympanostomy tube placement is among the most frequent surgical procedures performed in the pediatric population. It has been estimated that more than a million tympanostomy tubes may be placed each year, with typical patients being between about 18 months and 7 years of age at the time of the procedure.
Tympanostomy tube placement is typically performed in an out-patient surgery setting under general anesthesia. After administering the general anesthesia, the physician typically first examines the external auditory canal and tympanic membrane under microscopic visualization through a hand-held conical shaped speculum. The physician then makes an incision in the tympanic membrane (a “myringotomy”), typically using a standard, small profile scalpel which the physician advances through the conical speculum. The physician may then pass a suction device through the myringotomy into the middle ear, to aspirate fluid/effusion from the middle ear. The physician will then place the tympanostomy tube across the tympanic membrane, typically using a basic tool, such as forceps, for holding and advancing the tube into the myringotomy.
Systems and methods have been proposed for deploying tympanostomy tubes without having to use general anesthesia. Such systems are described for example in U.S. Patent Application Publication No. 2011/001564 (“Tympanic Membrane Pressure Equalization Tube Delivery System”), U.S. Patent Application Publication No. 2010/0198135 (“Systems and Methods for Anesthetizing Ear Tissue”), U.S. Patent Application Publication No. 2009/0163848 (“Iontophoresis Methods”), and U.S. Patent Application Publication No. 2009/0262510 (“Disposable Iontophoresis System and Tympanic Membrane Pain Inhibition Method”), each of which is incorporated by reference in their entirety. These publications describe integrated methods for delivering tympanostomy tubes and appropriate anesthesia, but do not describe how to personalize these systems for a particular patient, so that delivery of a tympanostomy tube can be achieved with minimal discomfort to the patient.
In light of the above, it would be desirable to provide improved devices, systems, and methods for delivering an anesthetizing solution into the ear canal. Such systems and methods would also be useful for administering other therapeutic solutions to the ear canal and tympanic membrane. It would generally be beneficial if these improvements facilitated tympanostomy tube placement without requiring multiple devices and operator-performed steps. At least some of these advantages may be provided by the embodiments described herein.
The present invention provides systems and methods for administering a therapeutic solution to the ear canal and/or for anesthetizing a tympanic membrane of an ear for surgical procedures such as placing a tympanostomy tube (or pressure equalization tube) across the tympanic membrane. The systems are personalizable to ensure proper anesthetizing solution and/or therapeutic solution administration.
In one aspect, the invention is directed to a method for administering a therapeutic solution to the ear canal of a patient. The method includes selecting or adjusting a headset based on a size and shape of the patient's head, positioning the headset about the patient's head and filling the ear canal with the therapeutic solution. An ear plug is inserted into the ear canal either prior to or following filling the ear canal.
In one embodiment, the method further includes selecting an ear plug based on a size and shape of the ear canal and positioning the selected ear plug onto the headset. In another embodiment, the method includes inserting the ear plug into the patient's ears prior to filling the ear canal with the therapeutic solution. In still another embodiment, the method includes inserting the ear plug into the patient's ear following filling the ear canal with the therapeutic solution. In yet another embodiment, the therapeutic solution may be administered to a second ear canal either simultaneously or sequentially. In a further embodiment, the headset comprises a first fill system valve through which the solution is administered to a first ear canal; and in another embodiment, the headset comprises a second fill system valve through which the solution is administered to a second ear canal. In a further embodiment, the solution is administered using a manual fill nozzle and in another, the therapeutic solution is retained in the ear canal throughout a predetermined treatment period. In another embodiment the method further includes removing the solution from the ear canal following the predetermined treatment period.
In another aspect, the invention is directed to a device for administering a therapeutic solution to the ear canal of a patient. The device includes a headset having a headset frame that is designed to conform to the size and shape of the patient's head and an ear plug that is designed to conform to the size and shape of the patient's ear canal.
In one embodiment of the device, the headset further comprises a fill system for filling the ear canal with the therapeutic solution. In another embodiment, the fill system includes a valve for attachment to a therapeutic solution delivery device, the valve being fluidly connected to a spray tip. In a further embodiment, the fill system includes a second valve, the second valve being fluidly connected to a second spray tip. In yet another embodiment, the headset includes locking arms, the locking arms having a first position and a second position, the first position permitting visualization of the ear canal, and the second position providing for sealing of the ear canal by the ear plug. In still another embodiment, the ear plugs further include a venting system selected from the group consisting of vent holes, vent slits and vent screens.
In a further aspect, the invention is directed to a method for administering a therapeutic solution to the ear canal of a patient and for delivering the solution to the tympanic membrane using iontophoresis. The method includes selecting or adjusting a headset based on a size and shape of the patient's head, the headset including an iontophoresis electrode connected to a control unit and a return electrode, positioning the headset about the patient's head, filling the ear canal with the therapeutic solution, attaching the return electrode to the patient and activating a control unit to initiate an iontophoresis procedure. The ear plug is inserted into the ear canal either prior to or following filling the ear canal.
In one embodiment, the method includes selecting an ear plug based on a size and shape of the ear canal and positioning the selected ear plug onto the headset. In another embodiment, the method includes inserting the ear plug into the patient's ears prior to filling the ear canal with the therapeutic solution where the iontophoresis electrode establishes electrical connection with the therapeutic solution during filling of the ear canal. In yet another embodiment, the ear plug is inserted into the patients ears following filling the ear canal with the therapeutic solution where the iontophoresis electrode establishes electrical connection with the therapeutic solution and in another, the therapeutic solution may be administered to a second ear canal either simultaneously or sequentially. In a further embodiment, the headset includes a first fill system valve through which the solution is administered to a first ear canal; and in another embodiment, the headset includes a second fill system valve through which solution is administered to a second ear canal. In a further embodiment, the substance is administered using a manual fill nozzle and in another, the therapeutic solution is retained in the ear canal throughout a predetermined treatment period. In yet another embodiment, the solution is removed from the ear canal following the predetermined treatment period.
In another aspect, the invention is directed to a device for administering a therapeutic solution to the ear canal of a patient and for iontophoresis delivery to the tympanic membrane. The device includes a headset having a headset frame that is designed to conform to the size and shape of the patient's head and an iontophoresis electrode that is connected to a control unit and a return electrode for delivering the solution into the tympanic membrane, and an ear plug that is designed to conform to the size and shape of the patient's ear canal.
In one embodiment, the headset further includes a fill system for filling the ear canal with the therapeutic solution. In another embodiment, the fill system includes a valve for attachment to a therapeutic solution delivery device, the valve being fluidly connected to a spray tip. In a further embodiment, the fill system includes a second valve, the second valve being fluidly connected to a second spray tip. In still another embodiment, the headset includes locking arms, the locking arms having a first position and a second position, the first position permitting visualization of the ear canal and the second position provides for sealing of the ear canal by the ear plug. In yet another embodiment the ear plugs further include a venting system selected from the group consisting of vent holes, vent slits and vent screens.
In a further aspect, the invention is directed to a method for anesthetizing a tympanic membrane of a human patient. The method involves inserting an ear plug sizer into a patient's ear canal to determine the appropriate ear plug size, and positioning the ear plug onto a headset. The headset is then positioned about the patient's head. The ear canal is filled with an anesthetizing solution and the ear plug of the headset is inserted into the patient's ear. The control unit is activated to begin the iontophoresis procedure.
In one embodiment, the method includes preparing the anesthetizing solution and warming it to body temperature. In a further embodiment the method of the invention includes filling the headset by injecting the solution into a fluid delivery channel of the headset until the solution exits the ear plugs. In yet another embodiment, the method of the invention includes removing air from the fluid delivery channel. The removal of air may be accomplished using a dual chamber instillation port, or by incorporating a semi-porous material into the fluid delivery channel.
In another aspect, the invention is directed to a method for filling and retaining fluid in the ear canal of a human patient. The method includes inserting an ear plug sizer into a patient's ear canal to determine the appropriate ear plug size and selecting an ear plug based on the determined appropriate ear plug size. The method further includes positioning the selected ear plug onto a headset, positioning the headset about the patient's head, and inserting the ear plug of the headset into the patient's ear for retaining said fluid in the patient's ear canal. The ear canal is filled with the fluid during the method for filling and retaining fluid in the patient's ear canal.
In a second aspect, the invention is directed to a system for anesthetizing a tympanic membrane of a human patient. The system includes ear plug sizers, iontophoresis electrodes, and ear plugs sized by said ear plug sizers for fluidly sealing an ear canal of the patient. The ear plugs are positioned about the iontophoresis electrodes. The system further includes a control unit and a headset. The headset includes a headset frame that fluidly connects the iontophoresis electrodes to a source of anesthetizing solution, and electrically connects the two electrodes to the control unit.
In one embodiment, the system includes temporal pads attached at the ends of the headset frame. In another embodiment, the system includes a wire support frame to support the ear plug in the x, y, and z directions. In a further embodiment, the headset frame is sized according to the size of the patient's head. In yet another embodiment, the headset frame includes accessories useful for watching and/or listening to movies, music or video games or attachments such as horns, antlers, antennas and elephant ears. In another embodiment, the anesthetizing solution includes lidocaine, lidocaine plus epinephrine or lidocaine, epinephrine and sodium bicarbonate.
In another aspect, the invention is directed to a headset for use in anesthetizing a tympanic membrane of a human patient. The headset includes a headset frame with a first headset arm and a second headset arm. The first headset arm includes a first iontophoresis electrode and a first fill system tip and the second headset arm includes a second iontophoresis electrode and a second fill system tip. The headset frame fluidly connects the iontophoresis electrodes and the fill system tips to a source of anesthetizing solution. The fill system tip has an atraumatic tip and at least one spray hole for delivering the anesthetizing solution to the tympanic membrane.
In one embodiment, the fill system tips comprise three spray holes spaced 120 degrees apart.
In a further aspect, the invention is directed to a headset for use in administering a solution into the ear canal of a human patient and retaining the solution in the ear canal. The headset has a headset frame with a first headset arm having a first fill system tip and a first earplug, and a second headset arm having a second fill system tip and a second earplug. The headset frame fluidly connects the fill system tips to a source of solution and the fill system tip has an atraumatic tip and spray holes for delivering the solution to the ear canal. The ear plugs retain the solution in the ear.
In one embodiment, the solution is selected from the group consisting of an anesthetizing solution, an antibacterial solution, an antifungal solution, an anti-inflammatory solution or a ceruminolytic solution.
In another aspect, the invention is directed to a device for administering a solution into the ear canal of a human patient. The device has a distal end with an atraumatic tip and at least one spray hole, a proximal end with a luer connector for attachment to a source of solution and a lumen between the proximal end and the distal end. The lumen has a bend angle of between about 0 and 140 degrees.
In one embodiment, the lumen has a bend angle of between about 120 and 140 degrees. In another embodiment, a speculum is fixedly attached to the device. In still another embodiment, the solution is selected from the group consisting of an anesthetizing solution, an antibacterial solution, an antifungal solution, an anti-inflammatory solution or a ceruminolytic solution.
In another aspect, the invention is an ear plug sizer kit for determining the appropriate ear plug for use in a human patient. The kit includes a first ear plug sizer having a first lug with a first outer diameter and a first ear plug with a first sealing diameter. The first lug is fixedly connected to a first end of a first shaft and the first ear plug is detachably connected to a second end of the first shaft. The kit further includes a second ear plug sizer having a second lug with a second outer diameter and a second ear plug with a second sealing diameter. The second lug is fixedly connected to a first end of a second shaft and the second ear plug is detachably connected to a second end of the second shaft. The first outer diameter is equivalent to the first sealing diameter and the second outer diameter is equivalent to the second sealing diameter.
In another aspect, the invention is a method for filling a patient's ear canal with a therapeutic solution while minimizing air bubbles in the ear canal. The method includes sealing the ear canal with an ear plug such that there is minimal leakage of the therapeutic solution from the ear canal, providing ear canal vents for venting air from within the ear canal, and turbulently filling the ear canal by administering the therapeutic solution through one or more spray holes in a fill system while venting the ear canal as a result of low pressure escape of air through the ear canal vents.
In one embodiment, the ear canal vents comprise ear plug vent holes and in another embodiment, the ear canal maintains a maximum pressure in the ear canal of 25 kilopascals.
In yet another aspect, the invention is a device for filling a patient's ear canal with a therapeutic solution while minimizing air bubbles in a patient's ear canal. The device includes an ear plug that is designed to conform to the size and shape of the patient's ear canal to seal the ear canal from leakage of the therapeutic solution, a fill system including an atraumatic tip portion and one or more spray holes to turbulently fill the ear canal with the therapeutic solution, and a vent system that is designed to maintain a maximum pressure in the ear canal at or below 25 kilopascals.
In one embodiment, the vent system comprises ear plug vent holes. In another embodiment, the fill system comprises three or more spray holes.
For a further understanding of the nature and advantages of the invention, reference should be made to the following description taken in conjunction with the accompanying figures. However, each of the figures is provided for the purpose of illustration and description only and is not intended to limit the scope of the embodiments of the present invention.
The embodiments of the invention are intended to provide systems that are useful for delivering and retaining a drug solution in a patient's ear canal that are individually and uniquely adapted to be used for a particular patient. In this way, variations in patient anatomy can be accommodated while maintaining patient comfort. Further, efficient filling of the ear canal can be accomplished under direct visualization with a microscope, limiting the amount of air bubbles in the ear canal, and facilitating the venting of excess air or fluid.
As can be imagined from
The headset 200 is useful for administering an iontophoretic substance to the ear canal and retaining it in the ear canal for anesthetizing the ear canal and tympanic membrane prior to treatment. The frame 202 serves to connect the portions of the headset together. These portions extend from the right side to the left side of the head and extend to the temporal pads 204a and 204b on the right and left side, respectively. The frame 202 is thus configured to be placed around or over a patient's head. Further, the frame 202 secures the headset 200 on the patient's head. In this way, the frame 202 is sized appropriately for the patient such that when in position over the patient's ears, the frame supplies a compressive force to the patient's head. A sizing aid may be used to determine the appropriate headset size. In some embodiments, the frames come in 3 sizes, small, medium and large, and in other embodiments, they may come in 2, 4, 5, 6 or more sizes. Further, in another embodiment, the frame may be expandable such that a single size may be supplied that can be adjusted according to the size of the patient's head. In other embodiments, accessories may be attached to the frame base to entertain a patient during the iontophoresis procedure. These accessories include, but are not limited to be re-usable glasses that can stream movies, music, and/or video games, fun attachments such as horns, antler, antennas, elephant ears, etc. Bone conduction could also be included such that a sound vibration element may be incorporated into the headset to entertain and/or distract a patient.
In a further aspect, the headset 200 may be useful for administering a drug solution or other therapeutic solution to the ear canal and retaining the solution in the ear canal for treating the ear canal or the tympanic membrane or for anesthetizing the ear canal or tympanic membrane. The electrodes, return electrode connector, electrode wiring and control unit connector would not be present in such system. Such solutions include but are not limited to antifungal or antibacterial agents such as benzalkonium chloride, boric acid, acetic acid, and clotrimazole, anti-inflammatory agents such as beclamethazone and antibiotic and steroids such as betnesol, prednisolone sodium phosphate, gentamycin, neomycin, and quinolones, astringent agents such as aluminum acetate, ceruminolytics such as sodium chloride solution, hydrogen peroxide or sodium bicarbonate solution. The solutions may be administered to one ear or both ears (unilaterally or bilaterally) and the solutions may be administered sequentially or simultaneously.
In order to ensure that the ear canal is completely filled with the drug solution, the ear canal may be initially filled manually with the therapeutic solution. Such filling of the ear canal may be done through the use of the manual fill nozzle shown in
Once the appropriate headset 200 has been chosen, the appropriate ear plugs may be chosen such that the plugs can be attached to the headset and can provide a seal to keep anesthetizing solution or other therapeutic solution in the ear canal 118. As shown in
In one embodiment, the ear plugs sizers 302a-f are provided as a set of six (6) color-coded parts and correspond to six (6) color-coded ear plug 304a-f sizes. Size 0 (the smallest) is purple (SD=0.276″, OD=0.323″), Size 1 is orange (SD=0.315″, OD=0.364″), Size 2 is green (SD=0.354″, OD=0.408″), Size 3 is yellow (SD=0.394″, OD=0.452″), Size 4 is red (SD=0.433″, OD=0.497″) and Size 5 is green (SD=0.472″, OD=0.548″). The shafts 310a-f of the ear plug sizers 302a-f are color-coded, rigid and attached to the ear plugs 304a-f, so that a health care professional can hold one of the ear plug sizers 302a-f and insert it into the ear canal of the patient prior to treatment to determine the appropriate size useful for the particular anatomy of the patient. The ear plug sizer that is believed to best match the opening of the ear canal should be used, and the health care professional should try one size larger and one size smaller to confirm the appropriate size. Once the proper ear plug is determined, it is placed over the locking arm elbow of the headset 200. The lumen of the tubular portion of the selected ear plug is pushed over the fill system tip 224a or 224b of the headset arm 208a or 208b until it seats into place against the lips 222a and 222b of the locking arm elbows 212a and 212b. The fill system tips 224a and 224b of the headset have three spray holes in an atraumatic tip for easy filling of the ear canal 118 through the fluid delivery channels 226a or 226b attached to the fill system valves 214a and 214b. The spray holes and atraumatic tip portion of the fill system tips 224a and 224b are similar to the spray holes 806 and atraumatic tip 808 of the manual fill nozzle 800 described below with regard to
The electrodes 210a and 210b consist of a solid silver electrode with a cylindrical shape attached to the electrode wiring 218 (see
Once the appropriate ear plug 304 has been placed on the appropriate headset 200, return electrode patch 400 is attached to the headset at the return electrode connector 220 by connection at the mechanically conductive return electrode snap 402. The return electrode patch 400 is shown in
Following positioning of the headset 200 on the patient's head and the return electrode patch 400 on the patient's skin as will be described below, the control unit 500 shown in
The method according to the invention is carried out according to
Once the headset 200 is properly primed and positioned, the auricle 100 of the ear is gently pulled to straighten the ear canal 118. Using the syringe with the manual fill nozzle 800 attached at the luer connector 802, the ear canal 118 is manually filled with anesthetizing solution (640), taking care to eliminate air bubble formation during the fill (see
The headset control unit connector 220 is connected to the control unit 500 until it snaps in place. The battery tab located on the back of the control unit case is removed. Empty status bars should appear on screen once the device is powered on. To start the iontophoresis procedure, the control unit is activated (660) by pressing the yellow button 502 and/or the blue button 504 on the control unit 500 are holding for 2 seconds. Each button controls an independent channel, with button colors corresponding to the colors of the left and right sides of the headset. A short beep confirms when a button has been activated. The control unit 500 is clipped to the patient's or the parent's clothing. The status bars will fill up to indicate each channel's progress toward completion. A typical procedure takes approximately 10 minutes, with each status bar segment representing approximately 20% of procedure time. A flashing segment indicates that current is running; a solid segment indicates the portion already completed. To pause the procedure, the button for the appropriate channel is pressed and held for 2 seconds. The pause symbol and status bar segment will both flash and then turn solid when current delivery has stopped. To resume the procedure, the same button is pressed and held for 2 seconds. The control unit 500 will play a long beep when each channel (yellow or blue side) has completed delivering a full dose. The status bars will also turn completely solid to indicate that full charge has been delivered through each channel. Once the tympanic membrane is anesthetized, to deactivate the control unit, the button for the appropriate channel is pressed and held for 2 seconds (670). Alternatively, the control unit may stop after a preset period of time of between about 5 minutes and 60 minutes, often between about 5 minutes and 30 minutes or about 10 minutes.
The procedure described above may also be useful for administering a therapeutic solution to the ear canal without the use of iontophoresis. The headset may be placed on the head of the patient and the ear may be primed with the therapeutic solution as described above followed by placement of the ear plugs into the ears, or the ear plugs may be inserted into the ears and the therapeutic solution administered through the headset fill system valves 214a and 214b. One or both of the valves (in this case, one way valves) are connected to delivery devices such as syringes or delivery pumps and the therapeutic solution is administered to one or both ear canals (unilaterally or bilaterally) either sequentially or simultaneously. As noted above, vent holes 318 are incorporated in the ear plugs to ensure that the ear canal is not over filled and thereby cause pressure to build up in the ear canal. Other vent systems for ensuring proper venting to ensure that patient comfort is maintained include but are not limited to vent slits and vent screens.
Proper sizing of the headset and the ear plugs ensure proper filling of the ear canal and further aid in retaining the therapeutic solution in the ear canal for a predetermined period of time that coincides with the duration of therapy. Such period of time may be from about five to ten minutes to about one to two hours. The therapeutic solution may be removed from the ear canal following the therapy by positioning of the patient's head, suctioning of the ear canal, or other procedures including but not limited to tympanocentesis.
In an alternative aspect of the invention, the manual fill nozzle 800 shown in
An alternative headset 700 is shown in
As noted above, according to the method of the invention, it is important to ensure that air bubbles in the anesthetizing solution or therapeutic solution are minimized Air bubbles may result from a variety of conditions including but not limited to orientation of the canal relative to gravity, surface tension of the liquid and surface conditions of the canal, such as a waxy ear canal wall. An alternative system is described for evacuating the external ear canal prior to filling such that minimal air bubbles are left behind in the anesthetizing solution. To enable reliable and tolerable filling of an ear canal in an awake patient, evacuation of entrapped air bubbles may be accomplished by providing a dual chamber instillation device. A first chamber of double or triple the volume of the liquid required to fill the canal is provided. This first chamber has a plunger or other means to forcibly expel liquid out and through an instillation port. A second chamber, vented to atmosphere, captures and stores excess liquid returning from the outlet port. Ear plugs with instillation and outlet ports are hydraulically balanced to enable filling of the ear canal with low pressure (supplied through the Instillation Chamber). Balancing is achieved by orifice diameter selection. The instillation port is constructed to create a turbulent flow at low exit pressure such that an irrigation effect is achieved, maximum surface wetting is obtained with minimum flow rate, and mobility of air bubbles is maximized. The slight positive pressure created within the ear canal mobilizes any air bubbles such that they will travel out of the outlet port. Low exit pressure is required to minimize the likelihood of pain due to high pressure jetting of liquid against sensitive tissue of the ear canal wall or tympanic membrane. Embodiments of the instillation port include tubing with a fine mesh screen to create separation and reduce fluid head, and alternatively, providing a tube with a coaxial, protracting structure to divert and separate flow.
In operation, the instillation chamber is filled with a volume greater than the volume of the ear canal. Ear plugs are inserted into the ear canal. The patient's ear canal is oriented vertically to reduce the likelihood of bubble entrapment. The plunger is driven to completely expel all liquid from the instillation chamber. The instillation device is disconnected from the plug and a fluid seal is maintained with bubbles evacuated.
Air in the fluid delivery channel and inside the electrode must be removed with low fluid pressure in order to minimize dead-space that would insulate the working electrode from the fluid and therefore increase system impedance. A method to manage air entrapment during application and use of anesthesia fluid is further described herein. Semi-porous material such as expanded polytetrafluoroethylene (EPTFE) or sintered solid EPTFE may be incorporated directly into the electrode housing or inside the ear canal interface of the device. The air in the fluid delivery channel and inside the electrode housing may be removed with low anesthetizing solution pressure since the required fluid pressure is inversely proportional to the porosity of the material used. To further remove entrapped air such as microbubbles in the system, a surfactant may be added to the anesthetizing solution to assist wetting and effectively decrease the surface tension of the incoming liquid to prevent formation of the bubble. Such surfactants may be any commonly used surfactant such as polyethylene glycol. During system filling, this would allow for dislodgement, coalescence and escape of microbubbles from the system through the semi-porous material. Other alternatives to remove entrapped air include a fluid-activated valve that would allow air to escape but would seal itself upon fluid entry, a one-way air valve incorporated in vent holes that would allow air and fluid to overflow but prevent any fluid from re-entering the system, an air reservoir in the system that would allow entrapped air to accumulate but strategically located not to disrupt anesthetizing solution delivery, or reducing surface tension by cleaning or etching the parts or enhancing their surface finishes such that microbubble formation is reduced.
Minimizing surface area on the inside of the ear plugs to prevent air bubbles from sticking to the inside surface of the ear ply and travelling into the elbow, blocking the conductance of the electrode is accomplished by providing 4 slots equally spaced at 90 degrees apart starting on the outside surface of the ear plug and travelling around to the inside diameter on the distal end of the ear plug. Flat surface are inside the ear plug creates tension between the air bubble and the earplug with allow the air bubbles to block electrode conductance. Slotted surface are minimized tension between air bubbles and the plug preventing such blockage.
Fluid leakage around the earplugs leads to air pockets in the ear canal that disrupt iontophoresis. With a constant pressure system, when fluid leaves the ear, it is immediately replaced, reducing air pocket development and further reducing user variability in delivering the fluid and the possibility of insufficient fluid in the ear canal. In an alternative embodiment of the invention, a compressed air canister is preloaded with a desired pressure. This air pressure is allowed to press against a piston, thereby delivering anesthetizing solution at a desired pressure. In an alternative embodiment, an expanding polymer such as polyacrylic acid can be used to created pressure, thereby propelling the anesthetizing solution once the polymer is wetted. Further embodiments would involve the use of a spring or rubber band to propel the anesthetizing solution or the use of a weight to press down on the anesthetizing solution with a constant gravitational force. Yet another embodiment would contemplate the acceleration of anesthetizing solution using an electrical charge to deliver precise pressure levels for delivery of the anesthetizing solution.
The invention has been described with reference to certain examples or embodiments of the invention, but various additions, deletions, alterations and modifications may be made to those examples and embodiments without departing from the intended spirit and scope of the invention. For example, any element or attribute of one embodiment or example may be incorporated into or used with another embodiment or example, unless otherwise specified or if to do so would render the embodiment or example unsuitable for its intended use. Also, where the steps of a method or process have been described or listed in a particular order, the order of such steps may be changed unless otherwise specified or unless doing so would render the method or process unworkable for its intended purpose. All reasonable additions, deletions, modifications and alterations are to be considered equivalents of the described examples and embodiments and are to be included within the scope of the following claims.
This application is a continuation of and claims priority to U.S. patent application Ser. No. 15/165,660, filed May 26, 2016, entitled “Personalizable System and Method for Anesthetizing the Tympanic Membrane” (now U.S. Pat. No. 10,195,369) which is a divisional of and claims priority to U.S. patent application Ser. No. 13/551,965, filed Jul. 18, 2012, entitled “Personalizable System and Method for Anesthetizing the Tympanic Membrane,” which claims the benefit of and priority to U.S. Provisional Patent Application No. 61/511,270, filed Jul. 25, 2011, entitled “Personalizable System and Method for Anesthetizing the Tympanic Membrane,” the contents of each of which are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
858673 | Roswell | Jul 1907 | A |
1920006 | Dozier et al. | Jul 1933 | A |
2458884 | Volkmann | Jan 1949 | A |
3741197 | Sanz et al. | Jun 1973 | A |
3888258 | Akiyama | Jun 1975 | A |
3897786 | Garnett et al. | Aug 1975 | A |
3913584 | Walchle et al. | Oct 1975 | A |
3948271 | Akiyama | Apr 1976 | A |
3991755 | Vernon et al. | Nov 1976 | A |
4149533 | Ishikawa et al. | Apr 1979 | A |
4206756 | Grossan | Jun 1980 | A |
4406282 | Parker et al. | Sep 1983 | A |
4468218 | Armstrong | Aug 1984 | A |
4473073 | Darnell | Sep 1984 | A |
4552137 | Strauss | Nov 1985 | A |
4564009 | Brinkhoff | Jan 1986 | A |
4601294 | Danby et al. | Jul 1986 | A |
4712537 | Pender | Dec 1987 | A |
4964850 | Bouton et al. | Oct 1990 | A |
4968296 | Ritch et al. | Nov 1990 | A |
4971076 | Densert et al. | Nov 1990 | A |
5026378 | Goldsmith, III | Jun 1991 | A |
5044373 | Northeved et al. | Sep 1991 | A |
5047007 | McNichols et al. | Sep 1991 | A |
5053040 | Goldsmith, III | Oct 1991 | A |
5107861 | Narboni | Apr 1992 | A |
5135478 | Sibalis | Aug 1992 | A |
5160316 | Henley | Nov 1992 | A |
5254081 | Maurer et al. | Oct 1993 | A |
5254120 | Cinberg et al. | Oct 1993 | A |
5261903 | Dhaliwal et al. | Nov 1993 | A |
D352780 | Glaeser et al. | Nov 1994 | S |
5421818 | Arenberg | Jun 1995 | A |
5466239 | Cinberg et al. | Nov 1995 | A |
5496329 | Reisinger | Mar 1996 | A |
5499971 | Shapland | Mar 1996 | A |
D378611 | Croley | Mar 1997 | S |
5610983 | Miyahara | Mar 1997 | A |
5643280 | Del Rio et al. | Jul 1997 | A |
5674196 | Donaldson et al. | Oct 1997 | A |
D387863 | Herman et al. | Dec 1997 | S |
5707383 | Bays et al. | Jan 1998 | A |
5792100 | Shantha | Aug 1998 | A |
5804957 | Coln | Sep 1998 | A |
5810848 | Hayhurst | Sep 1998 | A |
5827295 | Del Rio et al. | Oct 1998 | A |
5893828 | Uram | Apr 1999 | A |
5979072 | Collins, II | Nov 1999 | A |
D418223 | Phipps et al. | Dec 1999 | S |
D420741 | Croley | Feb 2000 | S |
6045528 | Arenberg et al. | Apr 2000 | A |
D424197 | Sydlowski et al. | May 2000 | S |
6059803 | Spilman | May 2000 | A |
D426135 | Lee | Jun 2000 | S |
6137889 | Shennib et al. | Oct 2000 | A |
6148821 | Falco et al. | Nov 2000 | A |
6183469 | Thapliyal et al. | Feb 2001 | B1 |
6200280 | Brenneman et al. | Mar 2001 | B1 |
6206888 | Bicek et al. | Mar 2001 | B1 |
6245077 | East et al. | Jun 2001 | B1 |
6251121 | Saadat | Jun 2001 | B1 |
6295469 | Linkwitz et al. | Sep 2001 | B1 |
D450843 | McGuckin, Jr. et al. | Nov 2001 | S |
6347246 | Perrault et al. | Feb 2002 | B1 |
6358231 | Schindler et al. | Mar 2002 | B1 |
6440102 | Arenberg et al. | Aug 2002 | B1 |
6475138 | Schechter et al. | Nov 2002 | B1 |
6512950 | Li et al. | Jan 2003 | B2 |
6514261 | Randall et al. | Feb 2003 | B1 |
6520939 | Lafontaine | Feb 2003 | B2 |
6522827 | Loeb et al. | Feb 2003 | B1 |
6553253 | Chang | Apr 2003 | B1 |
6640121 | Telischi et al. | Oct 2003 | B1 |
6645173 | Liebowitz | Nov 2003 | B1 |
6648873 | Arenberg et al. | Nov 2003 | B2 |
6663575 | Leysieffer | Dec 2003 | B2 |
6682558 | Tu et al. | Jan 2004 | B2 |
6770080 | Kaplan et al. | Aug 2004 | B2 |
6916159 | Rush et al. | Jul 2005 | B2 |
7123957 | Avrahami | Oct 2006 | B2 |
7127285 | Henley et al. | Oct 2006 | B2 |
7137975 | Miller et al. | Nov 2006 | B2 |
D535027 | James et al. | Jan 2007 | S |
7160274 | Ciok et al. | Jan 2007 | B2 |
7344507 | Briggs et al. | Mar 2008 | B2 |
7351246 | Epley | Apr 2008 | B2 |
7381210 | Zarbatany et al. | Jun 2008 | B2 |
D595410 | Luzon | Jun 2009 | S |
7563232 | Freeman et al. | Jul 2009 | B2 |
D598543 | Vogel et al. | Aug 2009 | S |
7654997 | Makower et al. | Feb 2010 | B2 |
7677734 | Wallace | Mar 2010 | B2 |
7704259 | Kaplan et al. | Apr 2010 | B2 |
7749254 | Sobelman et al. | Jul 2010 | B2 |
D622842 | Benoist | Aug 2010 | S |
8052693 | Shahoian | Nov 2011 | B2 |
8192420 | Morriss et al. | Jun 2012 | B2 |
8249700 | Clifford et al. | Aug 2012 | B2 |
8409175 | Lee et al. | Apr 2013 | B2 |
8425488 | Clifford et al. | Apr 2013 | B2 |
8452392 | Morriss et al. | May 2013 | B2 |
8498425 | Graylin | Jul 2013 | B2 |
8518098 | Roeder et al. | Aug 2013 | B2 |
8702722 | Shahoian | Apr 2014 | B2 |
8840602 | Morriss et al. | Sep 2014 | B2 |
8849394 | Clifford et al. | Sep 2014 | B2 |
9011363 | Clopp et al. | Apr 2015 | B2 |
9023059 | Loushin et al. | May 2015 | B2 |
9216112 | Clifford et al. | Dec 2015 | B2 |
9364648 | Girotra et al. | Jun 2016 | B2 |
9387124 | Clifford | Jul 2016 | B2 |
9392229 | Morriss et al. | Jul 2016 | B2 |
9707131 | Shahoian | Jul 2017 | B2 |
9713710 | Morriss et al. | Jul 2017 | B2 |
9833601 | Clifford | Dec 2017 | B2 |
9950157 | Morriss et al. | Apr 2018 | B2 |
10016304 | Ray et al. | Jul 2018 | B2 |
10130808 | Kermani et al. | Nov 2018 | B2 |
10195369 | Andreas et al. | Feb 2019 | B2 |
10258776 | Clifford et al. | Apr 2019 | B2 |
20020026125 | Leysieffer | Feb 2002 | A1 |
20020069883 | Hirchenbain | Jun 2002 | A1 |
20020111585 | Lafontaine | Aug 2002 | A1 |
20020138091 | Pflueger | Sep 2002 | A1 |
20020161379 | Kaplan et al. | Oct 2002 | A1 |
20020169456 | Tu et al. | Nov 2002 | A1 |
20030018291 | Hill et al. | Jan 2003 | A1 |
20030060799 | Arenberg et al. | Mar 2003 | A1 |
20030093057 | Zhang et al. | May 2003 | A1 |
20030120292 | Park et al. | Jun 2003 | A1 |
20030199791 | Boecker et al. | Oct 2003 | A1 |
20040054339 | Ciok et al. | Mar 2004 | A1 |
20050094835 | Doty | May 2005 | A1 |
20050154357 | Pinel | Jul 2005 | A1 |
20050182385 | Epley | Aug 2005 | A1 |
20050203552 | Laufer et al. | Sep 2005 | A1 |
20050235422 | Wallace | Oct 2005 | A1 |
20050240147 | Makower et al. | Oct 2005 | A1 |
20050284479 | Schrader et al. | Dec 2005 | A1 |
20060079957 | Chin et al. | Apr 2006 | A1 |
20060142700 | Sobelman et al. | Jun 2006 | A1 |
20060155304 | Kaplan et al. | Jul 2006 | A1 |
20060177080 | Smith | Aug 2006 | A1 |
20070003096 | Nam | Jan 2007 | A1 |
20070066946 | Haggstrom et al. | Mar 2007 | A1 |
20070078372 | Reddy et al. | Apr 2007 | A1 |
20070183613 | Juneau et al. | Aug 2007 | A1 |
20070233222 | Roeder et al. | Oct 2007 | A1 |
20080011308 | Fleming | Jan 2008 | A1 |
20080015540 | Muni | Jan 2008 | A1 |
20080051804 | Cottler et al. | Feb 2008 | A1 |
20080058756 | Smith | Mar 2008 | A1 |
20080065002 | Lobl et al. | Mar 2008 | A1 |
20080107287 | Beard | May 2008 | A1 |
20080212416 | Polonio et al. | Sep 2008 | A1 |
20080262468 | Clifford et al. | Oct 2008 | A1 |
20080262508 | Clifford et al. | Oct 2008 | A1 |
20080262510 | Clifford | Oct 2008 | A1 |
20090163848 | Morriss et al. | Jun 2009 | A1 |
20090209972 | Loushin et al. | Aug 2009 | A1 |
20090262510 | Pekkarinen et al. | Oct 2009 | A1 |
20090270807 | Mas et al. | Oct 2009 | A1 |
20090299344 | Lee et al. | Dec 2009 | A1 |
20100030131 | Morriss et al. | Feb 2010 | A1 |
20100041447 | Graylin | Feb 2010 | A1 |
20100061581 | Soetejo et al. | Mar 2010 | A1 |
20100198135 | Morriss et al. | Aug 2010 | A1 |
20100300460 | Falco et al. | Dec 2010 | A1 |
20110001564 | Hori | Jan 2011 | A1 |
20110015645 | Liu et al. | Jan 2011 | A1 |
20110048414 | Hoekman et al. | Mar 2011 | A1 |
20110268303 | Ahsani | Nov 2011 | A1 |
20110288559 | Shahoian | Nov 2011 | A1 |
20120109070 | Elsamahy et al. | May 2012 | A1 |
20120310145 | Clifford et al. | Dec 2012 | A1 |
20130090544 | Clifford et al. | Apr 2013 | A1 |
20130190678 | Andreas et al. | Jul 2013 | A1 |
20130197426 | Morriss et al. | Aug 2013 | A1 |
20130223702 | Holsing et al. | Aug 2013 | A1 |
20140102461 | Girotra et al. | Apr 2014 | A1 |
20140194891 | Shahoian | Jul 2014 | A1 |
20140276352 | Kermani et al. | Sep 2014 | A1 |
20140276906 | Andreas et al. | Sep 2014 | A1 |
20150068539 | Morriss et al. | Mar 2015 | A1 |
20160361204 | Girotra et al. | Dec 2016 | A1 |
20160375204 | Andreas et al. | Dec 2016 | A1 |
20170014272 | Ray et al. | Jan 2017 | A1 |
20170028193 | Morriss et al. | Feb 2017 | A1 |
20180085563 | Clifford et al. | Mar 2018 | A1 |
20180256894 | Morriss et al. | Sep 2018 | A1 |
20180304059 | Clifford et al. | Oct 2018 | A1 |
20180325737 | Ray et al. | Nov 2018 | A1 |
20190083780 | Kermani et al. | Mar 2019 | A1 |
Number | Date | Country |
---|---|---|
86105171 | Mar 1987 | CN |
2087067 | Oct 1991 | CN |
2409940 | Dec 2000 | CN |
19618585 | Nov 1997 | DE |
0214527 | Mar 1987 | EP |
2526656 | Nov 1983 | FR |
S59-129815 | Aug 1984 | JP |
H 07-116190 | May 1995 | JP |
2010-524584 | Jul 2010 | JP |
WO 9210223 | Jun 1992 | WO |
WO 1999017825 | Apr 1999 | WO |
WO 2002043795 | Jun 2002 | WO |
WO 2006119512 | Nov 2006 | WO |
WO 2008030485 | Mar 2008 | WO |
WO 2008036368 | Mar 2008 | WO |
WO 2008131195 | Oct 2008 | WO |
WO 2009010788 | Jan 2009 | WO |
WO 2009105619 | Aug 2009 | WO |
WO 2010014894 | Feb 2010 | WO |
WO 2011081772 | Jul 2011 | WO |
WO 2013016098 | Jan 2013 | WO |
WO 2013181009 | Dec 2013 | WO |
WO 2014158543 | Oct 2014 | WO |
WO 2017011777 | Jan 2017 | WO |
Entry |
---|
U.S. Appl. No. 60/912,902, filed Apr. 19, 2007. |
Patent Examination Report No. 1 for Australian Patent Application No. 2008242735, dated Aug. 8, 2012, 3 pages. |
Patent Examination Report No. 1 for Australian Patent Application No. 2013209354, dated Oct. 13, 2014, 5 pages. |
First Office Action for Chinese Patent Application No. 200880020861.9, dated Jul. 12, 2011, 10 pages. |
Second Office Action for Chinese Patent Application No. 200880020861.9, dated Dec. 31, 2011, 3 pages. |
Search Report for Chinese Patent Application No. 201310047126.X, dated Mar. 6, 2015, 2 pages. |
Second Office Action for Chinese Patent Application No. 201310047126.X, dated Mar. 16, 2015, 10 pages. |
Office Action for European Application No. 08746237.0, dated Mar. 24, 2016, 3 pages. |
Office Action for European Application No. 08746237.0, dated Aug. 4, 2015, 7 pages. |
Supplementary Partial Search Report for European Application No. 08746237.0, dated Jun. 30, 2014, 9 pages. |
Notification of Reasons for Refusal for Japanese Patent Application No. 2010-504267, dated Nov. 20, 2012, 4 pages. |
Notification of Reasons for Refusal for Japanese Patent Application No. 2010-504267, dated Nov. 12, 2013, 4 pages. |
International Search Report for International Application No. PCT/US2008/060779, dated Sep. 3, 2008. |
Written Opinion for International Application No. PCT/US2008/060779, dated Sep. 3, 2008. |
Office Action for U.S. Appl. No. 11/749,733, dated Jun. 10, 2009, 13 pages. |
Office Action for U.S. Appl. No. 11/749,733, dated Dec. 2, 2008, 9 pages. |
U.S. Appl. No. 61/085,360, filed Jul. 31, 2008. |
Patent Examination Report No. 1 for Australian Application No. 2009276384, dated Apr. 14, 2014, 3 pages. |
Office Action for Canadian Application No. 2,732,595, dated Dec. 8, 2015, 4 pages. |
Office Action for Russian Application No. 2011-07228, dated May 24, 2013. |
International Search Report for International Application No. PCT/US2009/052395, dated Nov. 6, 2009. |
Written Opinion for International Application No. PCT/US2009/052395, dated Nov. 6, 2009. |
Patent Examination Report No. 1 for Australian Application No. 2010337214, dated Feb. 27, 2015, 3 pages. |
Office Action for Chinese Application No. 201080065012.2, dated Mar. 31, 2016, 20 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2010/058718, dated Feb. 17, 2011, 12 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2010/042128, dated Aug. 27, 2010, 10 pages. |
Office Action for Australian Application No. 2012287268, dated Feb. 11, 2016. |
Office Action for Australian Application No. 2012287268, dated Jan. 13, 2017, 7 pages. |
Office Action for Canadian Application No. 2,843,147, dated May 31, 2018, 3 pages. |
Office Action for European Application No. 12743007.2, dated Jul. 21, 2016, 5 pages. |
Office Action for European Application No. 12743007.2, dated Jun. 12, 2017, 4 pages. |
Notification of Reasons for Refusal for Japanese Application No. 2014-522882, dated May 31, 2016. |
Office Action for Mexican Application No. MX/a/2014/001073, dated May 9, 2016, 3 pages. |
Office Action for U.S. Appl. No. 13/551,965, dated Sep. 10, 2015, 10 pages. |
Office Action for U.S. Appl. No. 13/551,965, dated Feb. 26, 2016, 10 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2012/047179, dated Mar. 11, 2013, 15 pages. |
Examination Report No. 1 for Australian Application No. 2017200513, dated Sep. 27, 2017, 4 pages. |
Notification of Reasons for Refusal for Japanese Application No. 2017-201670, dated Nov. 26, 2018, 8 pages. |
Office Action for U.S. Appl. No. 15/165,660, dated Jul. 14, 2017, 16 pages. |
Office Action for U.S. Appl. No. 15/165,660, dated Nov. 22, 2017, 12 pages. |
Office Action for U.S. Appl. No. 15/165,660, dated Mar. 26, 2018, 6 pages. |
First Office Action for Chinese Patent Application No. 201380027926.3, dated May 3, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2013/041816, dated Sep. 16, 2013, 14 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2014/018017, dated May 22, 2014, 12 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2016/042577, dated Dec. 6, 2016, 14 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2009/069388, dated Jun. 30, 2010, 16 pages. |
Comeau, M. et al., “Local Anesthesia of the Ear by Iontophoresis,” vol. 98, Arch. Otolaryngol., pp. 114-120 (Aug. 1973). |
Comeau, M. et al., “Anesthesia of the Human Tympanic Membrane by Iontophoresis of a Local Anesthetic,” The Larynogoscope, vol. 88, pp. 277-285 (1978). |
Echols, D. F. et al., “Anesthesia of the Ear by Iontophoresis of Lidocaine,” Arch. Otolaryngol., vol. 101, pp. 418-421 (Jul. 1975). |
Epley, J. M., “Modified Technique of Iontophoretic Anesthesia for Myringotomy in Children,” Arch. Otolaryngol., vol. 103, pp. 358-360 (Jun. 1977). |
Hasegawa, M. et al., “Iontophorectic anaesthesia of the tympanic membrane,” Clinical Otolaryngoloy, vol. 3, pp. 63-66 (1978). |
Ramsden, R. T. et al., “Anaesthesia of the tympanic membrane using iontophoresis,” The Journal of Laryngology and Otology, 56(9):779-785 (Sep. 1977). |
“Definition of Plenum,” Compact Oxford English Dictionary [online], Retrieved from the Internet: <http://oxforddictionaries.com/definition/english/plenum>, Retrieved on Aug. 6, 2012, 2 pages. |
“Definition of Plenum,” Merriam-Webster's Online Dictionary, 11th Edition [online], Retrieved from the Internet: <http://www.merriam-webster.com/dictionary/plenum>, Retrieved on Aug. 14, 2012, 1 page. |
Medtronic XOMED, “Activent® Antimicrobial Ventilation Tubes,” Rev. 1.1, pp. 1-4, 2002, Jacksonville, FL. |
Micromedics Innovative Surgical Products, “Micromedics Tympanostomy Tubes,” [online], Retrieved on Jul. 15, 2010, Retrieved from the Internet <URL: http://www.micromedics-usa.com/products/otology/micromedicstubes.htm>, 7 pages. |
JP OA for 2019-202174 dated Nov. 2, 2020, 5 pages. |
Number | Date | Country | |
---|---|---|---|
20190298940 A1 | Oct 2019 | US |
Number | Date | Country | |
---|---|---|---|
61511270 | Jul 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13551965 | Jul 2012 | US |
Child | 15165660 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15165660 | May 2016 | US |
Child | 16267010 | US |